Compare Sumitomo Bakelite Co., Ltd. with Similar Stocks
Dashboard
1
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 50.74
2
Low Debt Company with Strong Long Term Fundamental Strength
3
Positive results in Dec 25
4
With ROE of 8.06%, it has a fair valuation with a 1.55 Price to Book Value
5
Market Beating Performance
Stock DNA
Pharmaceuticals & Biotechnology
JPY 574,507 Million (Mid Cap)
19.00
NA
0.00%
-0.25
8.06%
1.75
Revenue and Profits:
Net Sales:
82,034 Million
(Quarterly Results - Mar 2026)
Net Profit:
8,431 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
51.6%
0%
51.6%
6 Months
46.04%
0%
46.04%
1 Year
96.71%
0%
96.71%
2 Years
66.08%
0%
66.08%
3 Years
39.62%
0%
39.62%
4 Years
79.35%
0%
79.35%
5 Years
61.36%
0%
61.36%
Sumitomo Bakelite Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
9.49%
EBIT Growth (5y)
18.85%
EBIT to Interest (avg)
50.74
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.25
Sales to Capital Employed (avg)
0.88
Tax Ratio
31.74%
Dividend Payout Ratio
45.47%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
12.76%
ROE (avg)
7.78%
Valuation key factors
Factor
Value
P/E Ratio
19
Industry P/E
Price to Book Value
1.55
EV to EBIT
13.03
EV to EBITDA
9.11
EV to Capital Employed
1.74
EV to Sales
1.37
PEG Ratio
0.34
Dividend Yield
NA
ROCE (Latest)
13.36%
ROE (Latest)
8.06%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
82,034.00
81,305.00
0.90%
Operating Profit (PBDIT) excl Other Income
12,308.00
12,397.00
-0.72%
Interest
123.00
25.00
392.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
8,431.00
6,500.00
29.71%
Operating Profit Margin (Excl OI)
105.10%
107.60%
-0.25%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 0.90% vs 3.10% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 29.71% vs 9.83% in Dec 2025
Annual Results Snapshot (Consolidated) - Mar'26
Mar'26
Mar'25
Change(%)
Net Sales
319,867.00
304,773.00
4.95%
Operating Profit (PBDIT) excl Other Income
48,747.00
44,805.00
8.80%
Interest
395.00
333.00
18.62%
Exceptional Items
-694.00
-5,517.00
87.42%
Consolidate Net Profit
28,366.00
19,531.00
45.24%
Operating Profit Margin (Excl OI)
107.80%
101.20%
0.66%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2026 is 4.95% vs 6.09% in Mar 2025
Consolidated Net Profit
YoY Growth in year ended Mar 2026 is 45.24% vs -10.98% in Mar 2025
About Sumitomo Bakelite Co., Ltd. 
Sumitomo Bakelite Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






